Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs THC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

THC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

THC Overall Winner 6-Pillar Tally: EHC 1 – 5 THC Matrix Metrics: EHC 4 – 6 THC

As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas THC carries 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin).

  • Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs THC
EHC NYSE
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
THC NYSE Head-to-Head Winner
Tenet Healthcare Corporation New
Services-General Medical & Surgical Hospitals, Nec
$263.19
-0.15% 1D
Market Cap $21.0B
TTM Revenue $22.2B
Forward P/E 13.0x
Beta / 30D Vol 0.53β · 44% Vol
Unified Composite Score
50.3 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 68.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.7 · SMA20: $277.89 · SMA50: $268.88

6-Pillar Scorecard Institutional Category Breakdown (EHC 1 – 5 THC)

Columns: Metric · EHC · THC
1. Valuation Multiples THC
Forward P/E 19.4x 13.0x
Trailing P/E 21.2x 7.7x
PEG Ratio 0.41x 1.79x
EV / Revenue 2.5x 1.4x
2. Growth & Scale THC
Revenue Growth (YoY) +8.9% +6.5%
Earnings Growth (YoY) +21.6% +221.5%
TTM Revenue (USD) $6.34B $22.2B
Market Cap $13.0B $21.0B
3. Profitability & Quality THC
Gross Margin 44.1% 42.5%
Operating Margin 18.4% 19.1%
Net Profit Margin 10.2% 13.1%
Return on Equity (ROE) 25.1% 41.7%
4. Balance Sheet & Cash Flow THC
Cash Generation (TTM) $457M $3.33B
Cash Flow Margin 7.2% 15.0%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $10.6B Net Debt (2.43x D/E)
Dividend Yield 0.58% None (0.00%)
5. Options & Positioning THC
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 27.0% (8th %ile) 39.9% (4th %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.92x (Balanced)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 23.4% of Rev ($5.18B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (4) vs THC (6)
Institutional Metric EHC THC Criterion Row Edge
Market Capitalization
Scale
$13.0B $21.0B Larger Scale THC
Trailing P/E Ratio
Valuation
21.2x 7.7x Lower Multiple THC
Forward P/E Ratio
Valuation
19.4x 13.0x Lower Multiple THC
Revenue Growth (YoY)
Growth
+8.9% +6.5% Higher Growth EHC
Operating Margin (TTM)
Profitability
18.4% 19.1% Higher Margin THC
Net Profit Margin
Profitability
10.2% 13.1% Higher Margin THC
Return on Equity (ROE)
Capital Efficiency
25.1% 41.7% Higher ROE THC
52-Week Range Position
Momentum
80% ($93–$144) 73% ($158–$301) Stronger Trend EHC
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.53β · 44% Vol Lower Realized Risk EHC
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 50.3 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $22.2B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 42.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev 1.79x PEG · 1.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) $3.33B ($10.6B Net Debt (2.43x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +8.81 pp
EHC: +6.06% · THC: -2.75%
3M Horizon EHC +16.06 pp
EHC: +10.53% · THC: -5.53%
6M Horizon THC +24.12 pp
EHC: +27.33% · THC: +51.45%
1Y Horizon THC +16.07 pp
EHC: +19.42% · THC: +35.49%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue THC Revenue EHC Op. Margin THC Op. Margin Margin Leader
FY2018 $4.28B $18.3B 13.0% 8.9% EHC
FY2019 $4.61B $18.5B 13.3% 8.3% EHC
FY2020 $3.57B $17.6B 15.8% 11.3% EHC
FY2021 $4.01B $19.5B 13.9% 14.7% THC
FY2022 $4.35B $19.2B 12.4% 12.2% EHC
FY2023 $4.80B $20.6B 7.3% 12.2% THC
FY2024 $5.37B $20.7B 8.5% 28.8% THC
FY2025 $5.94B $21.3B 9.5% 16.5% THC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
THC CONSOLIDATION
64d in phase · OBV DISTRIBUTION
Current IV 39.9%
IV Percentile 4th %ile
Put/Call OI Skew 0.92x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact THC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $291.54 · IV 37.5%

THC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($29,154)

Compare $29,154 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 37.5% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $290 / $320 Bull Call Spread

Buy 1x $290C · Sell 1x $320C · 32d

Net Entry $1,123 Debit
T+5d @ +5% Move +$461 (+41%)
Max Risk / Buffer $1,123 Capped
5d Edge & Liquidity 0.8x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $270 / $240 Bull Put Spread

Sell 1x $270P · Buy 1x $240P · 32d

Net Entry $382 Credit
Max Credit / Yield +$382 (+14.6% RoM)
Max Risk / Buffer -8.7% Cushion ($2,618 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $270P / $290-$320C Seagull

Sell 1x $270P · Buy 1x $290/$320C · 32d

Net Entry $671 Debit
T+5d @ +5% Move +$775 (+16.1% RoM)
Max Risk / Buffer -7.4% Put Cushion ($4,800 Mgn)
5d Edge & Liquidity 0.8x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
THC Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $21.0B market capitalization and 19.1% operating margin.
OpEx & R&D Reinvestment 23.4% of Rev ($5.18B)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs THC Key Questions & Quantitative Answers

As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas THC carries 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin). Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).

THC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with THC at +6.5% YoY revenue growth and +221.5% YoY earnings growth on $22.2B TTM revenue (42.5% gross margin, 19.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while THC shifted +16.4%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 23.4% of Rev ($5.18B) (0 disclosures) for THC.

THC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas THC trades at 13.0x Forward P/E, 7.7x Trailing P/E, 1.79x PEG, and 1.4x EV/Revenue (15.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus THC (41.7% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, THC carries 39.9% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.92x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.